Humana Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones

2025.12.01 21:58

I'm PortAI, I can summarize articles.

Humana Inc. (HUM) shares fell 1.44% to $242.23, outperforming competitors like UnitedHealth Group and Elevance Health, despite a general market downturn. The S&P 500 and Dow Jones also declined. Humana's stock is 23.19% below its 52-week high. Trading volume was below average. Data from Dow Jones Market Data and FactSet.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Humana Inc. (HUM) shed 1.44% to $242.23 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. This was the stock's second consecutive day of losses. Humana Inc. closed 23.19% short of its 52-week high of $315.35, which the company achieved on September 5th. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as UnitedHealth Group Inc. (UNH) fell 1.99% to $323.21, Elevance Health Inc. (ELV) fell 2.54% to $329.68, and Chubb Ltd. (CB) fell 0.78% to $293.88. Trading volume (1.6 M) remained 230,883 below its 50-day average volume of 1.9 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1658ET